脑恶性胶质瘤术后会师化疗同步适形放疗的临床观察

目的 探讨脑恶性胶质瘤显微手术全切后间质内尼莫司汀（ACNU）与替莫唑胺（TMZ）会师化疗同步适形放疗的临床疗效和安全性。方法 选取临床影像诊断为脑恶性胶质瘤的患者99例，均行开颅显微手术全切肿瘤和组织病理证实，术后采用单纯适形放疗( RT) 21 例，采用尼莫司汀间质化疗同步适形放疗( ACNU + RT) 24例，采用替莫唑胺化疗同步适形放疗( TMZ + RT) 23例，ACNU间质内化疗与口服TMZ会师化疗同步适形放疗(ACNU + TMZ + RT) 31例，比较四组的疗效和安全性。结果 脑恶性胶质瘤显微手术全切术后ACNU + TMZ +RT组患者1、2、3年存活率分别为80.6%(25/31)、48.4%(15 /31)、25.8%(8 /31)，中位生存时间为29.0（39.8～18.6）月。术后1、2、3年ACNU +TMZ + RT组中位生存时间明显长于RT组、ACNU + RT 组和TMZ + RT 组(χ_L²=21.045和22.385,P=0.043和0.045)；脑恶性胶质瘤显微手术全切术后ACNU + TMZ +RT组患者1、2、3年Karnofsky≥60所占比率分别为77.4%(24 /31)、48.4%(15 /31)、22.8%(8 /31)。术后1、2年ACNU+TMZ+RT组生存质量明显优于RT组、ACNU+RT 组及TMZ+RT组(χ²=8.199，P=0.042)、(χ²=7.864，P=0.049)。结论 脑恶性胶质瘤显微手术力争全切除，术后间质内ACNU与TMZ会师化疗同步适形放疗是脑恶性胶质瘤较优化的综合治疗方案，可显著延长患者的生存时间，提高患者的生存质量。

Effects of Rendezvous Chemotherapy Combined with Three-dimensional Conformal#br# Radiotherapy in Treatment for Post-operative Malignant Glioma

Objective To investigate the effi cacy and safety of rendezvous chemotherapy combined with threedimensionalconformal radiotherapy in the treatment for post-operative malignant glioma. Methods A totalof 99 patients with full resection of malignant glioma by microsurgery and confi rmed by histopathology werecollected. 21 patients were performed three-dimensional conformal radiotherapy alone (RT group), 24 patientsreceived nimustine interstitial chemotherapy combined with RT (ACNU +RT group), 23 patients were treatedwith temozolomide chemotherapy concurrent combined with RT (TMZ+RT group), and 31 patients receivednimustine interstitial chemotherapy rendezvous with temozolomide chemotherapy concurrent combined withRT (ACNU+TMZ+RT group). All patients were followed up for observation of median survival time, 1-, 2-,3-year survival rates and safety. Results The survival rates of 1-, 2- and 3-year of ACNU+TMZ+RT groupwere 80.6%(25/31), 48.4%(15/31) and 25.8%(8/31), and the median survival time was 29.0（39.8-18.6）months. The survival time of 1-, 2- and 3-year in ACNU +TMZ+RT group were signifi cantly longer than RT,ACNU +RT and TMZ+RT group（χ_L²=21.045, 22.385, P=0.043 and 0.045）. The KPS≥60 rates of 1-, 2-and 3-year in ACNU+TMZ+RT group were 77.4%(24/31), 48.4%(15 /31), 22.8%(8/31),respectively. The lifequality of 1-, 2-year in ACNU +TMZ+RT group were signifi cantly superior to RT, ACNU +RT and TMZ+RTgroup (χ²=8.199,P=0.042), (χ²=7.864,P=0.049). Conclusion With full resection of malignant glioma bymicrosurgery, rendezvous chemotherapy combined with three-dimensional conformal radiotherapy in thetreatment for post-operative malignant glioma is the optimum comprehensive treatment plan, which couldsignifi cantly extend patient’s survival time and improve the life quality.